Science Explorer Back to mapMap
Discussion
Researcher · Harvard University · United States

Christopher S. Kollmann

Christopher S. Kollmann publishes mostly in Molecular Biology, Infectious Diseases and Virology, on topics such as Chemical Synthesis and Analysis, HIV Research and Treatment and HIV/AIDS drug development and treatment.

ORCID 0009-0008-3338-9661 OpenAlex
World rank
#1,699,273
of 7,710,434 ranked researchers
Rank in United States
#525,451
of 1,627,098
Works
19
Citations
1.4k
Citations per work
71.5
h-index
10
i10-index 11Top 76% in Molecular Biology
Christopher S. Kollmann

What does Christopher S. Kollmann research?

Christopher S. Kollmann's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (20%), Immunology and Microbiology (17%).

Life Sciences: 10 works · 52.2% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 34.8% of their workMolecular Biology: 7 works · 34.8% of their workImmunology and Microbiology: 3 works · 17.4% of their workVirology: 2 works · 10.9% of their workImmunology: 1 works · 6.5% of their workEverything else: 5 works · 24.0% of their workHealth Sciences: 4 works · 19.5% of their workMedicine: 4 works · 19.5% of their workInfectious Diseases: 2 works · 13.0% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 6.5% of their workPhysical Sciences: 1 works · 4.3% of their workEarth and Planetary Sciences: 1 works · 4.3% of their workGeophysics: 1 works · 4.3% of their workTHEIR WORKChristopher S.Kollmann19works
Life Sciences52%Physical Sciences4%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology734.8%
    2. Immunology and Microbiology317.4%
  2. Everything else524.0%
    1. Medicine419.5%
    1. Earth and Planetary Sciences14.3%
  1. 1Molecular Biology35% of their works
  2. 2Infectious Diseases13% of their works
  3. 3Virology11% of their works
  4. 4Immunology6% of their works
  5. 5Radiology, Nuclear Medicine and Imaging6% of their works
  6. 6Geophysics4% of their works

Research topics

Which keywords describe Christopher S. Kollmann's research?

The keywords of their largest research topics: Antiretroviral Therapy, Drug Discovery, Foldamers, Peptide Synthesis, AIDS, Drug Resistance, HIV and HIV Infection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Antiretroviral Therapy102 topics
  2. Drug Discovery92 topics
  3. Foldamers71 topic
  4. Peptide Synthesis71 topic
  5. AIDS51 topic
  6. Drug Resistance51 topic
  7. HIV51 topic
  8. HIV Infection51 topic
  9. DNA nanotechnology31 topic
  10. Fc Receptors31 topic
  11. NK Cell Recognition31 topic
  12. Natural Killer Cells31 topic
  13. Ribosome31 topic
  14. Self-Assembly31 topic
  15. Therapeutic Antibodies31 topic
  16. Translation31 topic
  17. Click Chemistry21 topic
  18. Copper-Catalyzed Cycloaddition21 topic

Where does Christopher S. Kollmann work?

Christopher S. Kollmann's main affiliation in the publication record is Harvard University, United States.

How many publications and citations does Christopher S. Kollmann have?

OpenAlex counts 19 works and 1,358 citations for Christopher S. Kollmann, an h-index of 10, ranking #1,699,273 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christopher S. Kollmann. Posts are plain text and can be reported.